Drug costs determine therapy choice in newly-diagnosed diabetes

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.421, 2003-01, pp. : 9-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of Carvedilol Therapy on Autonomic Function and Baroreflex Sensitivity in Individuals with Newly-Diagnosed Essential Hypertension

By Strano S.

Clinical Drug Investigation, Vol. 19, Iss. 1, 2000-01 ,pp. : 63-70

Adis International

Access to resources Recommend Favorite

Use of palliative chemotherapy for newly-diagnosed incurable cancer

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 456, 2004-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Economic Model of First-Line Drug Strategies to Achieve Recommended Glycaemic Control in Newly Diagnosed Type 2 Diabetes Mellitus

By Ramsdell J.W.

PharmacoEconomics, Vol. 21, Iss. 11, 2003-01 ,pp. : 819-837

Adis International

Access to resources Recommend Favorite

Diagnosed diabetes costs US $174 billion

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 599, 2010-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

COPD costs depend on disease severity, drug therapy

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 297, 2001-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite